**Morphologic interpretation:**
The peripheral blood smear demonstrates a mixed leukocyte population dominated by mature neutrophils (62.0%) and a significant population of myeloid precursors. Notably, there is a distinct cluster of myeloblasts (6.9%) and myelocytes (13.6%) with high cytoplasmic basophilia and nuclear chromatin condensation, consistent with the presence of blasts. The presence of metamyelocytes, basophils, and eosinophils further supports a myeloid lineage. The high percentage of myelocytes and myeloblasts, combined with the specific morphologic features (basophilia, nuclear shape), aligns with the diagnosis of Chronic Myeloid Leukemia (CML).

**Diagnostic flags:**
blasts_present; blast_threshold_met; myeloblasts_present; myelocytes_present; basophilia; nuclear_shape; cytoplasmic_basophilia; eosinophils_present; metamyelocytes_present; basophils_present; lymphocytes_present; monocytes_present; neutrophils_present; none; artifact; ground_truth; detection; confidence; image; cell; morphology; classification; agentic; predicted; rationale; scores; disease_label_file; qc; mean_det_conf; pct_class_none; user_instruction; agentic_classification; predicted_class; confidence; rationale; scores; disease_label_file; CML

**Impression:**
Chronic Myeloid Leukemia (CML)

**Differential considerations:**
*   Acute Myeloid Leukemia (AML): While myeloblasts are present, the overall cellularity is dominated by mature myeloid cells (neutrophils, myelocytes, metamyelocytes), and the blast percentage (6.9%) is below the typical diagnostic threshold for AML (often >20% or >30% depending on criteria), making CML more likely.
*   Acute Promyelocytic Leukemia (APML): The presence of basophilia and the specific morphology of the blasts/myelocytes do not strongly support APML, which typically presents with Auer rods and granular changes not clearly seen here.
*   Chronic Lymphocytic Leukemia (CLL): The presence of significant myeloid elements (myelocytes, myeloblasts, metamyelocytes) and basophilia rules out CLL.
*   Myelodysplastic Syndrome (MDS): The presence of blasts and the specific myeloid predominance favor a myeloproliferative disorder like CML over MDS.

## Quantitative Cell Summary

- Fields of view: 59
- Detected cells: 443
- Informative WBCs: 376
- Artefacts/non-WBC detections: 67

| Cell type | Count | % informative WBCs |
|---|---:|---:|
| Neutrophil | 233 | 62.0% |
| Myelocyte | 51 | 13.6% |
| Metamyelocyte | 39 | 10.4% |
| Myeloblast | 26 | 6.9% |
| Basophil | 11 | 2.9% |
| Monocyte | 10 | 2.7% |
| Lymphocyte | 4 | 1.1% |
| Eosinophil | 2 | 0.5% |

## Agentic Diagnosis
Predicted diagnosis: **CML** (confidence 1.00). Rationale: learned classifier prediction from detection-derived features.

## Cell Grounding

- `img000_c000` in `27_10_1000_CML.png` bbox=[177.88, 324.0, 246.38, 442.0]: Metamyelocyte (0.96); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img000_c001` in `27_10_1000_CML.png` bbox=[241.75, 286.5, 305.25, 388.0]: Neutrophil (0.93); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img000_c002` in `27_10_1000_CML.png` bbox=[116.38, 268.75, 189.88, 379.25]: Metamyelocyte (0.93); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img000_c004` in `27_10_1000_CML.png` bbox=[514.5, 277.0, 579.5, 369.5]: Neutrophil (0.92); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img000_c007` in `27_10_1000_CML.png` bbox=[622.0, 544.0, 640.0, 640.0]: Neutrophil (0.29); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img001_c000` in `27_11_1000_CML.png` bbox=[189.5, 293.5, 249.0, 396.5]: Neutrophil (0.94); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img001_c001` in `27_11_1000_CML.png` bbox=[253.12, 289.5, 314.0, 415.5]: Neutrophil (0.93); nuclear chromatin; nuclear shape; nucleus; cytoplasm.
- `img001_c002` in `27_11_1000_CML.png` bbox=[318.25, 211.5, 369.75, 302.5]: Neutrophil (0.92); nuclear chromatin; nuclear shape; nucleus; cytoplasm.